Immunovant, Inc. - IMVT
About Gravity Analytica
Recent News
- 04.21.2025 - Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
- 03.19.2025 - Immunovant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies
Recent Filings
- 04.17.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.17.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.03.2025 - 4 Statement of changes in beneficial ownership of securities